U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417072) titled 'GenoDrugP 2025: Study on Three-dimensional Models Derived From Brain Tumors in Pediatric Patients' on Feb. 02.
Brief Summary: Central nervous system tumours are the most common solid tumours and the leading cause of cancer mortality in children, with high biological and prognostic heterogeneity. Despite advances in the 2021 WHO molecular classifications, treatment options remain limited and often ineffective in high-grade tumours. New third-generation sequencing technologies and three-dimensional models derived from patient tumours offer promising tools for more comprehensive genomic characterisation and preclinical evaluation of dr...